Profile: Richard Braatz
Richard Braatz: Moving past trial-and-error
Richard Braatz believes mathematics can help streamline the road to discovery in pharmaceutical manufacturing as well as nanotechnology.
RAS and PI 3-kinase Signaling Networks in Cancer
RAS and PI 3-kinase Signaling Networks in Cancer
Julian Downward - Cancer Research UK, London Research Center
MITES: Genomics Enrichment Course at the Broad
MITES: Genomics Enrichment Course at the Broad
This summer in Genomics, sixteen MITES students were transformed into research scientists. In groups of four, students researched monogenic disorders such as Early Onset Breast Cancer and sequenced the DNA of several individuals to discover novel human genetic ...
The Science and Business of RNAi Therapeutics
Lessons from Alnylam: The Science and Business of RNAi Therapeutics
Important lessons in the story of RNAi and Alnylam and their broader implications will be shared.
Inside the lab: Paul Chang, Ph.D.
Inside the lab: Paul Chang, Ph.D.
Learn more about the Chang lab's work to better understand a family of proteins, called PARPs, and how blocking specific PARPs might be a promising target for cancer therapies.
Inside the lab: Jacqueline A. Lees, Ph.D.
Inside the lab: Jacqueline A. Lees, Ph.D.
Learn more about the work that Professor Lees and her lab are doing to understand how proteins and pathways are mutated in cancer--and how they hope to make advances in detecting and hopefully treating osteosarcoma.
Imaging Zebrafish at MIT
Imaging Zebrafish at MIT
MIT researchers have invented a new imaging system that allowed them to create this three-dimensional rendering of the cartilage that forms the skull of a five-day-old zebrafish larva.
From Targets to Drugs for Cancer Patients
From Targets to Drugs for Cancer Patients
Edwin Clark - Merck Research Laboratories
Stephen Quake, $500K Lemelson-MIT Prize winner
Dr. Stephen Quake - 2012 $500,000 Lemelson-MIT Prize Winner
Profile of Dr. Stephen Quake, winner of the 2012 $500,000 Lemelson-MIT Prize for his revolutionary work in drug discovery, genome analysis and personalized medicine.
The Cancer Epigenome and Therapeutic Implications
11th Annual Koch Institute Symposium: The Cancer Epigenome and Therapeutic ...
Stephen Baylin, John Hopkins University, delivers remarks at the Koch Institute's 11th Annual Oncology Research Symposium
Stem Cells in Cancer: Do they Matter?
11th Annual Koch Institute Symposium: Stem Cells in Cancer: Do they Matter?
John Dick, Ontario Institute for Cancer Research, delivers remarks at the Koch Institute's 11th Annual Oncology Research Symposium
Role of Bmi I in Intestinal Development and Tumorigenesis
11th Annual Koch Institute Symposium: Role of Bmi I in Intestinal ...
Jacqueline Lees, Kock Institute at MIT, delivers remarks at the Koch Institute's 11th Annual Oncology Research Symposium
Introductory Remarks and Overview
11th Annual Koch Institute Symposium: Introductory Remarks and Overview
Tyler Jacks and Jacqueline Lees of the Koch Institute deliver remarks at the Koch Institute's 11th Annual Oncology Research Symposium
Epigenetic Mechanisms and Leukemia Development
11th Annual Koch Institute Symposium: Epigenetic Mechanisms and Leukemia ...
Scott Armstrong, Dana-Farber Cancer Institute, delivers remarks at the Koch Institute's 11th Annual Oncology Research Symposium
Dynamic and Coordinated Regulation of Developmental ...
11th Annual Koch Institute Symposium: Dynamic and Coordinated Regulation ...
Laurie Boyer, MIT, delivers remarks at the Koch Institute's 11th Annual Oncology Research Symposium
Collaboration Between Transcriptional and Epigenetic ...
11th Annual Koch Institute Symposium: Collaboration Between ...
Richard Young, Whitehead Institute, MIT, delivers remarks at the Koch Institute's 11th Annual Oncology Research Symposium
Closing Remarks
11th Annual Koch Institute Symposium: Closing Remarks
Tyler Jacks delivers closing remarks at the Koch Institute's 11th Annual Oncology Research Symposium